PHOTRONICS INC (PLAB) Fundamental Analysis & Valuation

NASDAQ:PLAB • US7194051022

Current stock price

48.06 USD
+2.22 (+4.84%)
Last:

This PLAB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. PLAB Profitability Analysis

1.1 Basic Checks

  • In the past year PLAB was profitable.
  • In the past year PLAB had a positive cash flow from operations.
  • Each year in the past 5 years PLAB has been profitable.
  • In the past 5 years PLAB always reported a positive cash flow from operatings.
PLAB Yearly Net Income VS EBIT VS OCF VS FCFPLAB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 7.18%, PLAB is in the better half of the industry, outperforming 73.91% of the companies in the same industry.
  • PLAB has a Return On Equity of 11.27%. This is in the better half of the industry: PLAB outperforms 74.78% of its industry peers.
  • PLAB has a better Return On Invested Capital (9.96%) than 81.74% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for PLAB is in line with the industry average of 10.70%.
Industry RankSector Rank
ROA 7.18%
ROE 11.27%
ROIC 9.96%
ROA(3y)7.8%
ROA(5y)7.34%
ROE(3y)12.05%
ROE(5y)11.43%
ROIC(3y)12.29%
ROIC(5y)11.75%
PLAB Yearly ROA, ROE, ROICPLAB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • With a decent Profit Margin value of 15.83%, PLAB is doing good in the industry, outperforming 75.65% of the companies in the same industry.
  • PLAB's Profit Margin has improved in the last couple of years.
  • Looking at the Operating Margin, with a value of 24.45%, PLAB belongs to the top of the industry, outperforming 82.61% of the companies in the same industry.
  • PLAB's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 35.14%, PLAB is doing worse than 60.87% of the companies in the same industry.
  • In the last couple of years the Gross Margin of PLAB has grown nicely.
Industry RankSector Rank
OM 24.45%
PM (TTM) 15.83%
GM 35.14%
OM growth 3Y-1.57%
OM growth 5Y18.52%
PM growth 3Y3.68%
PM growth 5Y23.71%
GM growth 3Y-0.36%
GM growth 5Y9.83%
PLAB Yearly Profit, Operating, Gross MarginsPLAB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. PLAB Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so PLAB is still creating some value.
  • PLAB has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, PLAB has less shares outstanding
  • The debt/assets ratio for PLAB has been reduced compared to a year ago.
PLAB Yearly Shares OutstandingPLAB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
PLAB Yearly Total Debt VS Total AssetsPLAB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 4.24 indicates that PLAB is not in any danger for bankruptcy at the moment.
  • PLAB has a Altman-Z score (4.24) which is comparable to the rest of the industry.
  • PLAB has a debt to FCF ratio of 0.00. This is a very positive value and a sign of high solvency as it would only need 0.00 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.00, PLAB belongs to the top of the industry, outperforming 86.09% of the companies in the same industry.
  • PLAB has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • PLAB's Debt to Equity ratio of 0.00 is fine compared to the rest of the industry. PLAB outperforms 72.17% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.24
ROIC/WACC0.85
WACC11.71%
PLAB Yearly LT Debt VS Equity VS FCFPLAB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • PLAB has a Current Ratio of 4.58. This indicates that PLAB is financially healthy and has no problem in meeting its short term obligations.
  • PLAB's Current ratio of 4.58 is fine compared to the rest of the industry. PLAB outperforms 66.96% of its industry peers.
  • PLAB has a Quick Ratio of 4.28. This indicates that PLAB is financially healthy and has no problem in meeting its short term obligations.
  • PLAB has a better Quick ratio (4.28) than 72.17% of its industry peers.
Industry RankSector Rank
Current Ratio 4.58
Quick Ratio 4.28
PLAB Yearly Current Assets VS Current LiabilitesPLAB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. PLAB Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 1.92% over the past year.
  • Measured over the past years, PLAB shows a very strong growth in Earnings Per Share. The EPS has been growing by 30.81% on average per year.
  • Looking at the last year, PLAB shows a decrease in Revenue. The Revenue has decreased by -0.06% in the last year.
  • PLAB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.85% yearly.
EPS 1Y (TTM)1.92%
EPS 3Y0.83%
EPS 5Y30.81%
EPS Q2Q%17.31%
Revenue 1Y (TTM)-0.06%
Revenue growth 3Y0.99%
Revenue growth 5Y6.85%
Sales Q2Q%6.09%

3.2 Future

  • The Earnings Per Share is expected to grow by 11.40% on average over the next years. This is quite good.
  • PLAB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.44% yearly.
EPS Next Y15.57%
EPS Next 2Y11.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.92%
Revenue Next 2Y5.44%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PLAB Yearly Revenue VS EstimatesPLAB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
PLAB Yearly EPS VS EstimatesPLAB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2 2.5

More info and screens

Find the best growth stocksShow best growing peers

5

4. PLAB Valuation Analysis

4.1 Price/Earnings Ratio

  • PLAB is valuated rather expensively with a Price/Earnings ratio of 22.67.
  • Compared to the rest of the industry, the Price/Earnings ratio of PLAB indicates a rather cheap valuation: PLAB is cheaper than 88.70% of the companies listed in the same industry.
  • PLAB is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.53, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 19.08 indicates a rather expensive valuation of PLAB.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of PLAB indicates a rather cheap valuation: PLAB is cheaper than 88.70% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of PLAB to the average of the S&P500 Index (37.95), we can say PLAB is valued slightly cheaper.
Industry RankSector Rank
PE 22.67
Fwd PE 19.08
PLAB Price Earnings VS Forward Price EarningsPLAB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PLAB indicates a rather cheap valuation: PLAB is cheaper than 100.00% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, PLAB is valued a bit cheaper than 79.13% of the companies in the same industry.
Industry RankSector Rank
P/FCF 42.99
EV/EBITDA 6.87
PLAB Per share dataPLAB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • PLAB has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.46
PEG (5Y)0.74
EPS Next 2Y11.4%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PLAB Dividend Analysis

5.1 Amount

  • PLAB does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PLAB Fundamentals: All Metrics, Ratios and Statistics

PHOTRONICS INC

NASDAQ:PLAB (4/17/2026, 12:04:41 PM)

48.06

+2.22 (+4.84%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)03-11
Earnings (Next)05-26
Inst Owners97.31%
Inst Owner Change0.13%
Ins Owners3.64%
Ins Owner Change-1.7%
Market Cap2.83B
Revenue(TTM)862.22M
Net Income(TTM)136.49M
Analysts84.44
Price Target47.19 (-1.81%)
Short Float %5.11%
Short Ratio2.74
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.69%
Min EPS beat(2)4.01%
Max EPS beat(2)29.38%
EPS beat(4)3
Avg EPS beat(4)11.48%
Min EPS beat(4)-19.14%
Max EPS beat(4)31.69%
EPS beat(8)5
Avg EPS beat(8)4.67%
EPS beat(12)7
Avg EPS beat(12)6.65%
EPS beat(16)9
Avg EPS beat(16)6%
Revenue beat(2)1
Avg Revenue beat(2)0.98%
Min Revenue beat(2)-1.11%
Max Revenue beat(2)3.08%
Revenue beat(4)2
Avg Revenue beat(4)0.08%
Min Revenue beat(4)-2.46%
Max Revenue beat(4)3.08%
Revenue beat(8)3
Avg Revenue beat(8)-2.06%
Revenue beat(12)4
Avg Revenue beat(12)-1.53%
Revenue beat(16)7
Avg Revenue beat(16)-0.65%
PT rev (1m)9.25%
PT rev (3m)7.02%
EPS NQ rev (1m)8%
EPS NQ rev (3m)8.72%
EPS NY rev (1m)7.98%
EPS NY rev (3m)7.71%
Revenue NQ rev (1m)-0.66%
Revenue NQ rev (3m)-0.95%
Revenue NY rev (1m)0.21%
Revenue NY rev (3m)-0.85%
Valuation
Industry RankSector Rank
PE 22.67
Fwd PE 19.08
P/S 3.29
P/FCF 42.99
P/OCF 10.63
P/B 2.34
P/tB 2.34
EV/EBITDA 6.87
EPS(TTM)2.12
EY4.41%
EPS(NY)2.52
Fwd EY5.24%
FCF(TTM)1.12
FCFY2.33%
OCF(TTM)4.52
OCFY9.41%
SpS14.62
BVpS20.54
TBVpS20.54
PEG (NY)1.46
PEG (5Y)0.74
Graham Number31.303 (-34.87%)
Profitability
Industry RankSector Rank
ROA 7.18%
ROE 11.27%
ROCE 12.44%
ROIC 9.96%
ROICexc 15.95%
ROICexgc 15.95%
OM 24.45%
PM (TTM) 15.83%
GM 35.14%
FCFM 7.65%
ROA(3y)7.8%
ROA(5y)7.34%
ROE(3y)12.05%
ROE(5y)11.43%
ROIC(3y)12.29%
ROIC(5y)11.75%
ROICexc(3y)20.09%
ROICexc(5y)18.3%
ROICexgc(3y)20.09%
ROICexgc(5y)18.3%
ROCE(3y)15.36%
ROCE(5y)14.68%
ROICexgc growth 3Y-10.62%
ROICexgc growth 5Y18.95%
ROICexc growth 3Y-10.62%
ROICexc growth 5Y19.05%
OM growth 3Y-1.57%
OM growth 5Y18.52%
PM growth 3Y3.68%
PM growth 5Y23.71%
GM growth 3Y-0.36%
GM growth 5Y9.83%
F-Score5
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 261.92%
Cap/Sales 23.27%
Interest Coverage 250
Cash Conversion 92.74%
Profit Quality 48.3%
Current Ratio 4.58
Quick Ratio 4.28
Altman-Z 4.24
F-Score5
WACC11.71%
ROIC/WACC0.85
Cap/Depr(3y)187.79%
Cap/Depr(5y)164.84%
Cap/Sales(3y)17.34%
Cap/Sales(5y)16.42%
Profit Quality(3y)93.18%
Profit Quality(5y)98.28%
High Growth Momentum
Growth
EPS 1Y (TTM)1.92%
EPS 3Y0.83%
EPS 5Y30.81%
EPS Q2Q%17.31%
EPS Next Y15.57%
EPS Next 2Y11.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.06%
Revenue growth 3Y0.99%
Revenue growth 5Y6.85%
Sales Q2Q%6.09%
Revenue Next Year5.92%
Revenue Next 2Y5.44%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2.48%
EBIT growth 3Y-0.59%
EBIT growth 5Y26.64%
EBIT Next Year48.72%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-61.78%
FCF growth 3Y-28.46%
FCF growth 5Y-3.72%
OCF growth 1Y-15.63%
OCF growth 3Y-3.44%
OCF growth 5Y11.62%

PHOTRONICS INC / PLAB Fundamental Analysis FAQ

What is the fundamental rating for PLAB stock?

ChartMill assigns a fundamental rating of 6 / 10 to PLAB.


Can you provide the valuation status for PHOTRONICS INC?

ChartMill assigns a valuation rating of 6 / 10 to PHOTRONICS INC (PLAB). This can be considered as Fairly Valued.


Can you provide the profitability details for PHOTRONICS INC?

PHOTRONICS INC (PLAB) has a profitability rating of 7 / 10.


What is the expected EPS growth for PHOTRONICS INC (PLAB) stock?

The Earnings per Share (EPS) of PHOTRONICS INC (PLAB) is expected to grow by 15.57% in the next year.